SSRI prescription during acute COVID-19 and risk of Long COVID symptoms and conditions among patients with depression
Butzin-Dozier, Z.; Ji, Y.; Wang, L.-C.; Kumar, M.; Anzalone, A. J.; Budhihartanto, A.; Hurwitz, E.; Patel, R. C.; Hubbard, A. E.; Halpern, J.; on behalf of the National Clinical Cohort Collaborative,
Show abstract
Background: Long COVID is a syndrome characterized by symptoms and conditions across all biological systems. This breadth of Long COVID phenotypes impedes efforts to identify the mechanistic pathways of Long COVID. Low serotonin may play a role in long-term sequelae of COVID-19, and selective serotonin reuptake inhibitors (SSRIs) may prevent these sequelae. Evaluation of the relationship between SSRIs and distinct categories of symptoms and conditions associated with Long COVID can highlight the mechanistic pathways that drive these relationships. Methods: We evaluated electronic health record data from a retrospective cohort of patients in the National Clinical Cohort Collaborative with comorbid depression and COVID-19 between October 2021 and February 2024. We estimated the relationship between SSRI prescription (versus no SSRI prescription) during acute COVID-19 and the one-year cumulative incidence of Long COVID-related conditions and symptoms across 14 human phenotype ontology categories. We applied Super Learner and targeted maximum likelihood estimation to estimate risk ratios while adjusting for confounders of interest and correcting for false discoveries from repeated testing. Results: We evaluated EHR data from 542,938 patients. We found that patients who were prescribed SSRIs during COVID-19 had a significantly lower risk of symptoms and conditions related to gastrointestinal factors (adjusted risk ratio (aRR) 0.95, 95% CI 0.92, 0.97), general health (aRR 0.91, 95% CI 0.88, 0.95), headaches (aRR 0.96, 95% CI 0.92, 0.99) and skin (aRR 0.92, 95% CI 0.87, 0.98). Discussion: We found that the prescription of SSRIs during acute COVID-19 was associated with a significantly lower risk of post-COVID sequelae related to gastrointestinal, headache-related, skin-related, and general symptoms and conditions, compared with no SSRI prescription. These findings highlight the role of serotonin in Long COVID and specific sequelae that may be reduced by SSRIs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antidepressant and mental health care utilization in pregnant women with depression and/or anxiety: an interrupted time-series analysis 93%
- Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme 93%
- ADHD in adults with recurrent depression 92%
Similar papers in this journal
- Decoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant Acceptability 93%
- Prevalence, Comorbidity, and Sociodemographic Correlates of Psychiatric Disorders in the All Of Us Biobank 93%
- Effect of everyday discrimination on depression and suicidal ideation during the COVID-19 pandemic: a large-scale, repeated-measures study in the All of Us Research Program 92%
Similar papers in this journal
- The development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies 94%
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP 92%
- Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study 92%
Similar papers in this journal
- Association between social media use and self-reported symptoms of depression in US adults 91%
- The Impact of the “Muslim Ban” Executive Order on Healthcare Utilization in Minneapolis-St. Paul, Minnesota 91%
- Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial 90%
Similar papers in this journal
- Stratifying Risk for Postpartum Depression at Time of Hospital Discharge 94%
- Trends in Prevalence of Cannabis Use Disorders among U.S. Veterans with and without Psychiatric Disorders Between 2005 and 2019 93%
- Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.